Get the Stockscreener App
0.772
1.31%
0.01
After Hours:
2.58
1.808
+234.20%
Pharmacyte Biotech Inc Stock (PMCB) Forecast
The Pharmacyte Biotech Inc (PMCB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.8922, representing a +145.10% increase from the current price of $0.772. The highest analyst price target is $1.9724, and the lowest is $1.812.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PMCB Price Target
Average 1.6154
(+109.24% Upside)
Is Pharmacyte Biotech Inc (PMCB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.03 | Neutral |
| STOCH(9,6) | 26.53 | Neutral |
| STOCHRSI(14) | 50.21 | Neutral |
| MACD(12,26) | -0.0449 | Sell |
| ADX(14) | 24.62 | Neutral |
| William %R | -67.14 | Neutral |
| CCI(14) | 1.1401 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7507
Buy
|
0.7713
Buy
|
| MA20 |
0.8631
Sell
|
0.8112
Sell
|
| MA50 |
0.8592
Sell
|
0.8625
Sell
|
| MA100 |
0.9238
Sell
|
0.9218
Sell
|
| MA200 |
1.0148
Sell
|
1.0729
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, PMCB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on PMCB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.03 indicates that PMCB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.53 indicates that PMCB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.21 indicates that PMCB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.62 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 1.1401 indicates that PMCB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PMCB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pharmacyte Biotech Inc financial reports and earnings history, Pharmacyte Biotech Inc (PMCB) stock could reach $0.5339 by 2030, $4.5914 by 2040 and $8.7679 by 2050. See the projected annual prices until 2050 of the Pharmacyte Biotech Inc stock below:
- Pharmacyte Biotech Inc (PMCB) is expected to reach an average price of $1.5175 in 2035, with a high prediction of $1.9489 and a low estimate of $1.6825. This indicates an $96.57% rise from the last recorded price of $0.772.
- Pharmacyte Biotech Inc (PMCB) stock is projected to chart a bullish course in 2040, with an average price target of $4.4036, representing an $470.42% surge from its current level. The forecast ranges from a conservative $4.7722 to a sky-high $4.5914.
- Our analysts predict Pharmacyte Biotech Inc (PMCB) to jump 427.65% by 2045, soaring from $4.2931 to an average price of $4.0735, potentially reaching $4.2019. While $4.2931 is the low estimate, the potential upside is significant.
- Pharmacyte Biotech Inc (PMCB) stock is expected to climb by 2050, reaching an average of $8.7812, a $1,037% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.7679 and $8.8112, respectively, highlighting the market's uncertainty.
Pharmacyte Biotech Inc Stock (PMCB) Year by Year Forecast
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2026
The predicted value for Pharmacyte Biotech Inc (PMCB) in 2026 is set at an average of $1.6154. Estimates vary from a peak of $2.227 to a trough of $1.0037, indicating an +109.24% surge from the present price of $0.772.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $1.872 | $1.812 | $1.9724 | +142.49% |
| March, 2026 | $1.8949 | $1.7384 | $1.9849 | +145.45% |
| April, 2026 | $2.0409 | $1.6809 | $2.081 | +164.37% |
| May, 2026 | $2.1538 | $2.0341 | $2.1838 | +178.99% |
| June, 2026 | $1.8666 | $1.8034 | $2.227 | +141.79% |
| July, 2026 | $1.6827 | $1.6827 | $1.9198 | +117.97% |
| August, 2026 | $1.432 | $1.3356 | $1.7559 | +85.49% |
| September, 2026 | $1.3716 | $1.3416 | $1.6774 | +77.67% |
| October, 2026 | $1.1345 | $1.0045 | $1.3348 | +46.95% |
| November, 2026 | $1.2473 | $1.0541 | $1.3273 | +61.57% |
| December, 2026 | $1.2934 | $1.0037 | $1.4834 | +67.54% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pharmacyte Biotech Inc (PMCB) is $0.8692, with a high forecast of $1.7312 and a low forecast of $0.00711. This indicates an +12.59% increase from the last price of $0.772.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.2562 | $1.2162 | $1.443 | +62.72% |
| February, 2027 | $1.3091 | $1.2194 | $1.4627 | +69.57% |
| March, 2027 | $1.2352 | $1.1361 | $1.3687 | +59.99% |
| April, 2027 | $1.588 | $1.088 | $1.648 | +105.70% |
| May, 2027 | $1.2809 | $1.2309 | $1.7312 | +65.91% |
| June, 2027 | $0.7964 | $0.4764 | $1.60 | +3.16% |
| July, 2027 | $0.9321 | $0.4557 | $1.4257 | +20.74% |
| August, 2027 | $0.5428 | $0.155 | $0.8786 | -29.68% |
| September, 2027 | $0.22 | $0.00711 | $0.5971 | -71.51% |
| October, 2027 | $0.1643 | $0.0908 | $0.2364 | -78.71% |
| November, 2027 | $0.0586 | $0.1286 | $0.1349 | -92.41% |
| December, 2027 | $0.3865 | $0.1322 | $0.2965 | -49.93% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2028
In 2028, Pharmacyte Biotech Inc (PMCB) is projected to reach an average price of $0.4475, with a high projection of $0.8948 and a low estimate of $0.000152. This indicates an -42.04% fall from the last price of $0.772.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4508 | $0.45 | $0.4408 | -41.61% |
| February, 2028 | $0.1051 | $0.3878 | $0.3344 | -86.39% |
| March, 2028 | $0.233 | $0.2122 | $0.1294 | -69.82% |
| April, 2028 | $0.2473 | $0.2837 | $0.1573 | -67.97% |
| May, 2028 | $0.2851 | $0.208 | $0.1851 | -63.07% |
| June, 2028 | $0.1194 | $0.1294 | $0.2287 | -84.53% |
| July, 2028 | $0.0563 | $0.000152 | $0.1698 | -92.71% |
| August, 2028 | $0.3284 | $0.0027 | $0.5756 | -57.46% |
| September, 2028 | $0.2441 | $0.0741 | $0.4441 | -68.38% |
| October, 2028 | $0.6198 | $0.077 | $0.6998 | -19.71% |
| November, 2028 | $0.7019 | $0.5491 | $0.8819 | -9.08% |
| December, 2028 | $0.6976 | $0.5076 | $0.8948 | -9.63% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2029
The 2029 price forecast for Pharmacyte Biotech Inc Stock (PMCB) is $0.6465 on average, with a high prediction of $1.224 and a low estimate of $0.0689. This represents an -16.26% decrease from the previous price of $0.772.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8298 | $0.5941 | $0.8848 | +7.48% |
| February, 2029 | $0.8355 | $0.6955 | $0.9064 | +8.22% |
| March, 2029 | $0.8912 | $0.7563 | $0.9148 | +15.44% |
| April, 2029 | $0.8069 | $0.6969 | $0.9176 | +4.52% |
| May, 2029 | $0.869 | $0.7133 | $0.9497 | +12.57% |
| June, 2029 | $1.1247 | $0.6619 | $1.1247 | +45.69% |
| July, 2029 | $1.0504 | $0.9403 | $1.224 | +36.06% |
| August, 2029 | $0.8625 | $0.8068 | $1.0418 | +11.73% |
| September, 2029 | $0.5383 | $0.4583 | $0.879 | -30.28% |
| October, 2029 | $0.5804 | $0.3711 | $0.6839 | -24.82% |
| November, 2029 | $0.2461 | $0.1361 | $0.7258 | -68.12% |
| December, 2029 | $0.2618 | $0.0689 | $0.396 | -66.09% |
Pharmacyte Biotech Inc Stock (PMCB) Price Forecast for 2030
Pharmacyte Biotech Inc Stock (PMCB) is expected to reach an average price of $0.662 in 2030, with a high forecast of $1.2365 and a low forecast of $0.0875. This signifies an -14.25% decrease from the last price of $0.772.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.4339 | $0.0875 | $0.5339 | -43.79% |
| February, 2030 | $0.4396 | $0.3432 | $0.5768 | -43.05% |
| March, 2030 | $0.5453 | $0.3225 | $0.5753 | -29.36% |
| April, 2030 | $0.491 | $0.3754 | $0.5467 | -36.40% |
| May, 2030 | $0.3432 | $0.2712 | $0.4975 | -55.55% |
| June, 2030 | $0.7289 | $0.2339 | $0.8824 | -5.59% |
| July, 2030 | $0.5835 | $0.3917 | $0.7753 | -24.42% |
| August, 2030 | $0.6211 | $0.7511 | $0.5607 | -19.55% |
| September, 2030 | $0.7925 | $0.7522 | $0.5825 | +2.66% |
| October, 2030 | $1.1034 | $0.8929 | $0.8641 | +42.93% |
| November, 2030 | $1.3958 | $1.1247 | $1.1658 | +80.80% |
| December, 2030 | $1.3872 | $1.3861 | $1.2365 | +79.69% |
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):